← Back to headlines
MicroVision and Profusa Regain Nasdaq Listing Compliance
Medical technology firms MicroVision and Profusa have successfully met Nasdaq’s continued listing standards, reversing previous delisting risks. The regulatory compliance updates have stabilized their stock valuations and restored full trading privileges on the exchange.
31 Aug, 12:56 — 31 Aug, 13:37
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (37/100)3 sources25/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left
Center2
Center (2)
morningstarinvesting-com
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US3
ℹAll sources from US region
Sources
Showing 2 of 3 sources
morningstar17h ago
MicroVision Regains Compliance with Nasdaq's Continued Listing Requirements - Morningstar
MicroVision Regains Compliance with Nasdaq's Continued Listing Requirements Morningstar
Read full article →investing-com18h ago
Profusa regains compliance with Nasdaq listing requirements
By Investing.com
Read full article →Coverage Timeline
First report: investing-com · 31 Aug, 12:56|Full coverage: 3 · 41m|Window: 41m
Left-leaningCenterRight-leaning
